FDA and CMS: A Path for Parallel Approvals for Innovative Technologies
01 April 2012
Medical Design
Publication
Authors:
Judith A. Waltz
Medical Design
Partner Judith Waltz authored an article that appeared in Medical Design on April 1, 2012 titled "FDA and CMS: A path for parallel approvals for innovative technologies."
Click here to read the complete article.
Click here to read the complete article.
Authors
Related Services
Industry Teams
Insights
Protecting and Enforcing IP Rights in Bankruptcy: Five to Thrive (For Starters)
19 February 2020
Manufacturing Industry Advisor
SCOTUS Agrees to Take on ERISA Preemption Once Again!
19 February 2020
Legal News: Employee Benefits Insights
Remodeling your Artificial Intelligence IP Strategy: Top 3 reasons to invest in your IP
19 February 2020
Privacy, Cybersecurity & Technology Law Perspectives
ERISA Litigation Isn’t Slowing Down – Tips to Help Plan Fiduciaries Keep Ahead of It
19 February 2020
Legal News: Employee Benefits Insights
Former SEC Official and Prominent Securities Enforcement Attorney Joins Foley in Denver
18 February 2020
Overly Quoted in IT World About How DDoS Attacks Evolve
13 February 2020
IT World
Sims Discusses Pilot Pro Bono Program Aimed at Clearing Appeals Backlog
12 February 2020
Chicago Daily Law Bulletin
2020 AANP National Conference
23-28 June 2020
New Orleans, LA
gpTRAC 2020 – Telehealth Everywhere 2020 Conference
17-19 May 2020
Bloomington, MN
Utilization Management: Addressing Crucial Challenges for Health Plans (Insight Exchange Network Health Care Conference)
23-24 April 2020
Fort Lauderdale, FL
Washington Executive Certification Course for Healthcare Compliance Executives
20-22 April 2020
Alexandria, VA